Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Smoking Cessation 1Smoking 1Sinonasal undifferentiated carcinoma 1Radiation Injuries 1Paranasal Sinus Neoplasms 1Oropharyngeal Neoplasms 1NSCLC 1Lung Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1Glioblastoma 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Cardiovascular Diseases 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pegfilgrastim 1Gemcitabine 1Cystectomy 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Infiltrating Bladder Urothelial Carcinoma × Chemoradiotherapy × Clear all
NCT03609216 2026-04-13

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
237 enrolled
Genitourinary

Infiltrating Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡